The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis
- PMID: 11208653
- DOI: 10.1164/ajrccm.163.1.2005004
The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis
Abstract
Lymphangiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex (TSC). Because only a minority of women with TSC develops symptomatic LAM, we hypothesized that a relationship might exist between the type of germline TSC1 or TSC2 gene mutation and the risk of developing LAM. We examined all 41 exons of the TSC2 gene and 21 coding exons of the TSC1 gene for mutations in a group of 14 women with both TSC and LAM using single-strand conformation polymorphism analysis. Seven mutations were found in TSC2 and one in TSC1. Of the seven patients with TSC2 mutations, two had the same in-frame exon 40 deletion and one had an exon 41 missense change. We conclude that germline mutations in the extreme carboxy-terminus of tuberin can result in LAM. Further studies will be required to determine whether mutations in exons 40 and 41 are associated with an increased incidence and/or severity of LAM in women with TSC.
Similar articles
-
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.J Hum Genet. 2002;47(1):20-8. doi: 10.1007/s10038-002-8651-8. J Hum Genet. 2002. PMID: 11829138
-
Metastasis of benign tumor cells in tuberous sclerosis complex.Genes Chromosomes Cancer. 2003 Dec;38(4):376-81. doi: 10.1002/gcc.10252. Genes Chromosomes Cancer. 2003. PMID: 14566858 Review.
-
Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.J Med Genet. 2000 Jan;37(1):55-7. doi: 10.1136/jmg.37.1.55. J Med Genet. 2000. PMID: 10633137 Free PMC article.
-
Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.Hum Mutat. 1999;14(5):412-22. doi: 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K. Hum Mutat. 1999. PMID: 10533067
-
A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.J Intern Med. 2004 Aug;256(2):166-73. doi: 10.1111/j.1365-2796.2004.01356.x. J Intern Med. 2004. PMID: 15257730 Review.
Cited by
-
Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality.Sci Rep. 2014 Aug 4;4:5927. doi: 10.1038/srep05927. Sci Rep. 2014. PMID: 25088526 Free PMC article.
-
"T"eeing Up A Novel Therapy for Lymphangioleiomyomatosis.Am J Respir Cell Mol Biol. 2020 Jun;62(6):678-680. doi: 10.1165/rcmb.2020-0049ED. Am J Respir Cell Mol Biol. 2020. PMID: 32101457 Free PMC article. No abstract available.
-
Functional characterisation of the TSC1-TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex.BMC Med Genet. 2008 Feb 26;9:10. doi: 10.1186/1471-2350-9-10. BMC Med Genet. 2008. PMID: 18302728 Free PMC article.
-
Metastatic Angiosarcoma of the Scalp Presenting with Cystic Lung Lesions: A Case Report and Review of Cystic Lung Diseases.Perm J. 2018;22:17-168. doi: 10.7812/TPP/17-168. Perm J. 2018. PMID: 30005733 Free PMC article. Review.
-
Lymphangioleiomyomatosis.Atlas Genet Cytogenet Oncol Haematol. 2009;13(10):751-757. Atlas Genet Cytogenet Oncol Haematol. 2009. PMID: 26478749 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical